Home/ Stocks/ KZR

Kezar Life Sciences, Inc. Common Stock

KZR XNAS

$7.29 +0.01 (+0.14%) ▲ 15-min delayed

Open

$7.36

High

$7.47

Low

$7.27

Volume

616.0K

Market Cap

$53.86M

About Kezar Life Sciences, Inc. Common Stock

Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 9 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$0	$-56,033,000	$-7.66
FY 2025	$0	$-56,033,000	$-7.66
Q3 2025	$0	$-11,227,000	$-1.53
Q1 2025	$0	$-16,556,000	$-2.27

Related Market News

No specific coverage for KZR yet. Check out our latest market news or earnings calendar.

Get KZR Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Kezar Life Sciences, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.